Small Molecule Therapeutics for Schizophrenia

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Celanire, Sylvain (Επιμελητής έκδοσης), Poli, Sonia (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
• Σειρά: Topics in Medicinal Chemistry, 13
• Θέματα: Chemistry.; Neurosciences.; Medicinal chemistry.; Psychopharmacology.; Medicinal Chemistry.

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry i...

Πίνακας περιεχομένων:

• Antipsychotics and the Dopamine–Serotonin Connection
• GLYT1 Inhibitors: From Hits to Clinical Candidates
• Metabotropic Glutamate Receptor 2 Activators
• Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders
• Muscarinic Acetylcholine Receptor Activators
• Nicotinic Acetylcholine Receptor Modulators
• The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.